NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/09/2023
Back to search
Official data from USPTO
ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/09/2023
Trademark type
Combined
Nice classes
44
Filing date
09/19/2016
Registration date
08/22/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/09/2023
Last transaction
03/09/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2016-09-00
First use in commerce
2016-10-00
Drawing code
3
Owner type
03
Owner location
Philadelphia, PA
Examiner
ROSSMAN, MARY
Law office
L90
Current location
TMEG LAW OFFICE 109
Mark description
The mark consists of a circular spiral comprised of a solid circular center surrounded by polka dots with the text "ID YOUR IRD" appearing next to the spiral design with the wording "ID YOUR IRD" all appearing on separate lines with the wording "INHERITED RETINAL DISEASE GENE TESTING INITIATIVE" appearing centered below on two lines.
Holders and representatives
Holders
Spark Therapeutics, Inc.
Representatives
Susan A. Smith Ballard Spahr LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
25 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2023
E815
TEAS SECTION 8 & 15 RECEIVED
08/23/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/18/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/16/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/12/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/08/2017
IUAF
USE AMENDMENT FILED
04/17/2017
EISU
TEAS STATEMENT OF USE RECEIVED
04/17/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2017
PUBO
PUBLISHED FOR OPPOSITION
02/14/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/25/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/30/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
12/29/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/29/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
12/29/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/29/2016
DOCK
ASSIGNED TO EXAMINER
12/24/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/23/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2016
NWAP
NEW APPLICATION ENTERED
09/22/2016
Continuous trademark protection
Get notified about every new filing that threatens ID YOUR IRD INHERITED RETINAL DISEASE GENE TESTING INITIATIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.